Treatment of patients with chronic HCV infection with native or pegylated IFNα is associated with a number of neuropsychiatric side-effects including fatigue, depression, cognitive disturbances and in some cases suicidal tendencies [103]. This evidence concerns the gene IFNA1 and depressive disorder.